Author:
An Lei,Xu Hongen,Chen Shuqing,Wu Guangyao,Yi Ming,Liu Chang,Wang Zhenxing,Wang Chunli,Shi Zeyuan,Niu Chenguang,Duan Shaofeng,Li Xiaodong,Tang Wenxue,Wu Kongming,Wang Yueqiang
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference45 articles.
1. Geographic Variation in EGFR Mutation Frequency in Lung Adenocarcinoma May Be Explained by Interethnic Genetic Variation;L Soraas;J. Thorac. Oncol,2018
2. Overall survival benefits of first-line EGFR tyrosine kinase inhibitors in EGFR-mutated non-small-cell lung cancers: a systematic review and meta-analysis;F C Kuan;Br. J. Cancer,2015
3. Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer;S Wang;J. Hematol. Oncol,2016
4. Efficacy and safety of first line treatments for patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: systematic review and network meta-analysis;Y Zhao;BMJ,2019
5. Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer;P T Harrison;Semin. Cancer. Biol,2020